Fervent Pharmaceuticals   Report issue

For profit Phase 2
Founded: Greenville NC United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2018
NCT03285672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fervent Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (1)

fp-101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1